UBS Upgrades GE HealthCare Techs to Neutral, Lowers Price Target to $69

Benzinga Newsdesk www.benzinga.com Negative 76.3%

Neg 76.3% Neu 0% Pos 0%

UBS analyst Graham Doyle upgrades GE HealthCare Techs (NASDAQ:GEHC) from Sell to Neutral and lowers the price target from $75 to $69.